Ke Wang
Algemeen Directeur bij CHANGZHOU QIANHONG BIOPHARMA CO.,LTD
Vermogen: 47 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Ke Wang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ke Wang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Changzhou Bio-pharma Qianhong Co. Ltd. | Chairman Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | ||
Hubei Runhong Biotechnology Co. Ltd.
 Hubei Runhong Biotechnology Co. Ltd. BiotechnologyHealth Technology Part of Changzhou Qianhong Biopharma Co., Ltd., Hubei Runhong Biotechnology Co. Ltd. is a Chinese company that manufactures and distributes biochemical products. The company is based in Zhongxiang, China. Hubei Runhong Biotechnology Co. was acquired by Changzhou Qianhong Biopharma Co., Ltd. on June 11, 2015 for $1.37 million. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| Zonhon Biopharma Institute, Inc. | Director/Board Member Director/Board Member Director/Board Member | ||
| Changzhou Biochemistry Pharmaceutical Factory | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| Jiangsu Pharmaceutical Association | Corporate Officer/Principal Corporate Officer/Principal | ||
| Nanjing University | College/University | Undergraduate Degree Graduate Degree | |
| Chinese Pharmaceutical Association | Director/Board Member | ||
Shanghai Innostar Biotechnology Co., Ltd.
 Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| YSB INC. | Packaged Software | Director/Board Member | |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | Information Technology Services | Director/Board Member | |
| JINLING HOTEL CORPORATION, LTD. | Hotels/Resorts/Cruise lines | Director/Board Member | |
| Nanjing University of Science & Technology | College/University | Comptroller/Controller/Auditor | |
| SUNING.COM CO., LTD. | Electronics/Appliance Stores | Director/Board Member | |
| JIANGSU GUOXIN CORP. LTD. | Electric Utilities | Director/Board Member | |
| LINHAI CO.,LTD. | Trucks/Construction/Farm Machinery | Director/Board Member | |
| Jiangsu Audit Society | Corporate Officer/Principal | ||
| Jiangsu Association of Chief Financial Officers | Director/Board Member | ||
| NANTONG HAIXING ELECTRONICS CO., LTD. | Aluminum | Director/Board Member | |
| JIANGSU EXPRESSWAY COMPANY LIMITED | Other Transportation | Director/Board Member | |
| JIANGSU HUAXICUN CO.,LTD. | Textiles | Director/Board Member | |
| Accounting Society of China | Corporate Officer/Principal | ||
| JIANGSU CANOPUS WISDOM MEDICAL TECHNOLOGY CO.,LTD. | Medical Specialties | Director/Board Member | |
| Chinese Academy of Sciences | College/University | Doctorate Degree | |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | College/University | Corporate Officer/Principal | |
Hainan Hualon Pharmaceutical Co., Ltd.
 Hainan Hualon Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Hainan Hualon Pharmaceutical Co., Ltd. manufactures medical equipment. The private company is based in Haikou, China. and has subsidiaries in China. The Chinese company was founded in 1995. The CEO is Yi Zhi Chen. | Medical Specialties | Director/Board Member | |
| JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD | Biotechnology | Director/Board Member | |
| China Pharmaceutical University | College/University | Corporate Officer/Principal | |
| Shenyang Pharmaceutical University | College/University | Doctorate Degree | |
| Changzhou Institute of Certified Public Accountant | Corporate Officer/Principal | ||
Jiangsu Suya Jincheng Certified Public Accountants Co., Ltd.
 Jiangsu Suya Jincheng Certified Public Accountants Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Jiangsu Suya Jincheng Certified Public Accountants Co., Ltd. is a company based in Nanjing, China. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Changzhou Changshen Certified Public Accountants Co. Ltd. | Corporate Officer/Principal | ||
| JIANG SU SUYAN JINGSHEN CO.,LTD | Chemicals: Agricultural | Director/Board Member | |
| SUMEC CORPORATION LIMITED | Trucks/Construction/Farm Machinery | Director/Board Member | |
| JIANGSU JINGXUE INSULATION TECHNOLOGY CO.,LTD. | Industrial Specialties | Director/Board Member | |
| China Biochemical Pharmaceutical Industry Association | Corporate Officer/Principal | ||
| Jiangsu Pharmaceutical Profession Associaiton | Corporate Officer/Principal | ||
| Changzhou Pharmaceutical Industry Association | Corporate Officer/Principal | ||
| Changzhou Drug Pricing Assocation | Corporate Officer/Principal | ||
| I-MAB | Pharmaceuticals: Major | Director/Board Member | |
| Jiangsu Pharmaceutical Quality Control Association | Corporate Officer/Principal | ||
| Changzhou Pharmaceutical Association | Corporate Officer/Principal | ||
| Changzhou Biochemical Pharmaceutical Co. Ltd. | Corporate Officer/Principal | ||
| Jiangsu Biological Technology Association | Corporate Officer/Principal | ||
Aucentra Therapeutics Pty Ltd.
 Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Biotechnology | Director/Board Member | |
| Jiangsu Institute of Biochemistry & Molecular Biology | Corporate Officer/Principal | ||
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| JIANGSU CHANGHAI COMPOSITE MATERIALS CO., LTD | Miscellaneous Manufacturing | Director/Board Member | |
| HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Qingdao University of Science & Technology | College/University | Undergraduate Degree |
Statistieken
Internationaal
| China | 46 |
| Kaaimaneilanden | 2 |
| Hongkong | 2 |
| Verenigde Staten | 2 |
| Australië | 2 |
Sectoraal
| Health Technology | 9 |
| Consumer Services | 9 |
| Producer Manufacturing | 4 |
| Process Industries | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 45 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 26 |
| Chairman | 6 |
| Comptroller/Controller/Auditor | 3 |
Sterkste connecties
| Insiders | |
|---|---|
| Guang Hua Xu | 12 |
| Rong Shao | 12 |
| Yao Fang Wang | 8 |
| Xing Hua Rong | 8 |
| Gang Zhao | 6 |
| Jun Liu | 5 |
| Yong Fan | 5 |
| Wen Qun Jiang | 4 |
| Ji Wen Zhang | 4 |
| Jian Ping Jiang | 2 |
| Li Jun Wei | 2 |
| Zhu Qing Zhang | 2 |
| Lei Chen | 2 |
| Xiang Zhou | 2 |
| Tao Hai | 1 |
